Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

ACLX Arcellx Inc

76,69

-1,66 (-2,12%)

31 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Arcellx (NASDAQ:ACLX)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Arcellx Charts.

Arcellx (NASDAQ:ACLX)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Arcellx Charts.

News Arcellx Inc

Form 8-K - Current report
Montag 9 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients With Relapsed or Refractory Multiple Myeloma to be Presented During an Oral Presentation at the 66th ASH Annual Meeting and Exposition
Montag 9 Dezember 2024 (3 Wochen vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 20 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 13 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 8 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Arcellx Provides Third Quarter 2024 Financial Results and Business Highlights
Donnerstag 7 November 2024 (2 Monate vor) • Business Wire

Form 8-K - Current report
Dienstag 5 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Arcellx to Present Clinical Data for Its Phase 1 and iMMagine-1 Studies in Patients with Relapsed or Refractory Multiple Myeloma at the 66th ASH Annual Meeting and Exposition and Announces Progress in iMMagine-3 Study
Dienstag 5 November 2024 (2 Monate vor) • Business Wire

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Dienstag 22 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Arcellx Inc News-Artikel

JP Morgan Chase

Gold vs US Dollar

Euro vs Sterling

Financial Select Sector

BNP Paribas (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen